Somatic SF3B1 mutations are found in approximately 30% of patients with MDS and as many as 80% of patients with the MDS subtype characterized by ring sideroblasts (MDS-RARS) [41, 56, 57]. Here, SF3B1 is linked to myelodysplastic syndrome.